ANXA1 and bronchopulmonary dysplasia: In addition, we observed reduced abundance of several protease inhibitors in the BPD and PTlow groups, including ANXA1, SERPINB3, CSTA and SLPI, with reduced abundance of SLPI being noted in both BPD and PTlow groups.